Carolinas Medical Center
Radiation Therapy Center
1000 Blythe Boulevard
Charlotte, North Carolina 28232
Telephone: 704-355-2272
Fax Number: 704-355-7218
Atlanta, Georgia
Married with three children
Wake Forest University
Winston-Salem, North Carolina
B.S. in Biology and History
(Magna Cum Laude, Honors in History, and Dean's List seven semesters)
Emory University School of Medicine
Atlanta, Georgia
M.D. - Doctor of Medicine
Emory University School of Medicine
Atlanta, Georgia
Resident in Medicine-Preliminary
Emory University School of Medicine
Department of Radiation Oncology
Atlanta, Georgia
(Chief Resident: 7/98 to 12/98 & 7/99 to 6/00)
Southeast Radiation Oncology Group, P.A.
Charlotte, North Carolina
North Carolina—2000-00192
South Carolina—20728
Georgia—042023
5/16/00
Kent LM, Brennan MT, Noll JL, Fox PC, Burri SH, Hunter JC, Lockhart PB. Radiation-Induced trismus in head and neck cancer patients. Support Care Cancer. Oct 27. 2007. In press.
Welsh J, Sanan A, Gabayan AJ, Green SB, Lustig R, Burri SH, Kwong E, Stea B. GliasSite Brachytherapy Boost as part of Initial Treatment of Glioblastoma Multiforme:A Retrospective Multi-Institutional Pilot Study. International Journal of Radiation Oncology Biology Physics 68(1):159-165. 2007.
Kavanagh BD, Schefter TE, Cardenes HR, Stieber VW, Raben D, Timmerman RD, McCarter MD, Burri SH, Nedzi LA, Sawyer TE, Gaspar LE. Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncologica. 45(7):848-55. 2006.
Gabayan AJ, Green S, Sanan A, Jenrette J, Schultz C, Papagikos M, Tatter SP, Patel A, Amin P, Lustig R, Bastin K, Watson G, Burri SH, Stea B. GliaSite Brachytherapy for treatment of recurrent malignant gliomas: A retrospective multi-institutional analysis. Neurosurgery April 58(4):701-708. 2006.
Burri SH, Asher AL. Brain Metastases. Continuum: Neuro-Oncology editor David Schiff, American Academy of Neurology. In press-publication scheduled for 10/05.
Asher AL, Burri SH, Shaffrey ME. Brain Metastases. Principles of Neuro-Oncology editor David Schiff, McGraw-Hill Professional, publication date 3/05.
Shaffrey ME, Mut M, Asher A, Burri SH, Chahlavi A, Chang SM, Farace E, Fiveash JB, Lang FF, Lopes MB, Markert JM, Schiff D, Siomin V, Tatter SB, Vogelbaum MA. Brain Metastases. Current Problems in Surgery Aug;41(8):665-741. 2004.
Burri SH, Landry JC, Norton J, Davis LW. Black and White Patients fare equally well when treated with Post-Lumpectomy Radiotherapy. Journal of the National Medical Association July; 96(7):961-967. 2004.
Burri SH, Asher A, Shaffrey M. In regard to Hasegawa et al. Brain metastases treated with radiosurgery alone: an alternative to whole brain radiotherapy? Neurosurgery April 54(4):1033-1035. 2004.
Burri SH, Asher A. In regard to Regine et al. Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications. International Journal of Radiation Oncology Biology Physics Aug 1;53(5):1393-4. 2002.
Burri SH, Landry JC, Davis LW . Breast conservation is an effective option in Black, medically indigent patients. Journal of the National Medical Association Jun;94(6):453-8. 2002.
Burri SH, Kim CN, Fang G, Chang BS, Perkins C, Harris W, Davis LW, Thompson CB, Bhalla KN. 'Loop' Domain Deletional Mutant of Bcl-XL is as effective as p29 Bcl-XL in inhibiting Radiation-Induced Cytosolic Accumulation of Cytochrome C, Caspase-3 Activity and apoptosis. International Journal of Radiation Oncology Biology Physics 43:2 423-430. 1999.
Poster Presentation. The use of Glia-Site in the primary management of brain metastases results in a high rate of radiation necrosis and re-operation. 12th Annual Meeting of the Society for Neuro-Oncology. Dallas, Texas. November 2007.
Poster Presentation. Neo-adjuvant pre-operative stereotactic radiosurgery in the management of brain metastases that require surgical resection. 57th Annual Meeting of the Congress of Neurological Surgeons. San Diego, California. October 2007.
Poster Presentation. Pre-operative radiosurgery in the management of symptomatic brain metastases. 56th Annual Meeting of the Congress of Neurological Surgeons. Chicago, Illinois. October 2006.
Poster Presentation. Long-term follow-up of balloon-based brachytherapy (Glia-site) for treatment of high-grade gliomas and brain metastases is associated with a rising risk of radiation necrosis, but few late failures. 9th Annual Meeting of the Society for Neuro-Oncology. Toronto, Ontario. November 2004.
Poster Presentation. Encouraging early results using the Glia-Site brachytherapy device as a portion of initial therapy for malignant gliomas. 8th Annual Meeting of the Society for Neuro-Oncology. Keystone, Colorado. November 2003. Oral Presentation. Black and White Patients fare equally well when treated with Post-Lumpectomy Radiotherapy. 42nd Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO). Boston, Massachusetts. October 2000.
Oral Presentation. Black and White Patients fare equally well when treated with Post-Lumpectomy Radiotherapy. 42nd Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO). Boston, Massachusetts. October 2000.
Oral Presentation. Breast Conservation is an Effective Option in Black, Medically Indigent Patients. 85th Annual Meeting of the Radiologic Society of North America (RSNA). Chicago, Illinois. November 1999.
Oral Presentation. 'Loop' Domain Deletional Mutant of Bcl-XL is as effective as p29 Bcl-XL in inhibiting Radiation-Induced Cytosolic Accumulation of Cytochrome C, Caspase-3 Activity and Apoptosis. 40th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO). Phoenix, Arizona. October, 1998.
Oral Presentation Effect of Bcl-XL or its 'Loop' Deletional Mutant Expression on irradiation-induced Cytosolic Cytochrome c, Caspase-3 Activity and Apoptosis. 89th Annual Meeting of the American Association for Cancer Research (AACR). New Orleans, LA. March, 1998.
Burri SH, Asher AL, Mueller M, Fraser RW. The use of Glia-Site in the primary management of brain metastases results in a high rate of radiation necrosis and re-operation. Neuro-Oncology 9(4):586#RT-23. 2007.
Sheehan J, Burri SH, Laws ER, Farace E. Delay in radiation leads to shorter length of survival in GBM:Analysis of the glioma outcomes data. Neuro-Oncology 9(4):581RT-3. 2007.
Burri SH, Asher AL, Mueller ML, Cagle S, Fraser RW. Neo-adjuvant pre-operative stereotactic radiosurgery in the management of brain metastases that require surgical resection. Proceeding of Congress of Neurological Surgeons 57th Annual Meeting San Diego, California October 2007.
Burri SH, Asher AL, Fraser RW. Pre-operative Radiosurgery in the Management of Symptomatic Brain Metastases. Proceeding of Congress of Neurological Surgeons 56th Annual Meeting Chicago, Illinois, October 2007.
Burri SH, Asher AL, Norton HJ, Fraser RW. Long-term follow-up of balloon-based brachytherapy (Glia-site) for treatment of high-grade gliomas and brain metastases is associated with a rising risk of radiation necrosis, but few late failures. Neuro-Oncology 6(4):359#RT-03. 2004.
Gabayan AJ, Sanan A, Bastin K, Burri SH, Green S, Jenrette J, Lustig R, Papagikos M, Patel A, Schultz C, Watson G, Stea B. Glia-Site radiation therapy system for the treatment of recurrent malignant glioma: A multi-institutional analysis. International Journal of Radiation Oncology Biology Physics 60:1S 258#1002. 2004.
Gabayan AJ, Sanan A, Bastin K, Burri SH, Green S, Jenrette J, Lustig R, Papagikos M, Patel A, Schultz C, Watson G, Stea B. Glia-Site radiation therapy system for the treatment of recurrent malignant glioma: A multi-institutional analysis. Radiotherapy and Oncology 71(2):S62. 2004.
Burri SH, Sills AK, Fraser RW, Asher AL. Encouraging early results using the GliaSite brachytherapy device as a portion of initial therapy for malignant gliomas. Neuro-Oncology 5(4):349#TA-07. 2003.
Burri SH, Landry JC, DeWolfe KD, Godette KD, Machuta SR, Davis LW. Black and White Patients fare equally well when treated with Post-Lumpectomy Radiotherapy. International Journal of Radiation Oncology Biology Physics 48:3S 196#169. 2000.
Burri SH, Smith RG, Landry JC, Ghavidel S, Davis LW. Breast Conservation is an Effective Option in Black, Medically Indigent Patients. Supplement to Radiology 213(P): 202#447. November, 1999.
Burri SH, Kim CN, Fang G, Davis LW, Bhalla KN. 'Loop' Domain Deletional Mutuant of Bcl-XL is as effective as p29 Bcl-XL in inhibiting Radiaiton-Induced Cytosolic Accumulation of Cytochrome C, Caspase-3 Activity and Apoptosis. International Journal of Radiation Oncology Biology Physics 42:1S 137#25. 1998.
Burri SH, Liu L, Perkins C, Davis LW, Bhalla KN. Effect of Bcl-XL or its 'Loop' Deletional Mutant Expression on irradiation-induced Cytosolic Cytochrome C, Caspase-3 Activity and Apoptosis. Proceedings of the American Association for Cancer Research 39: 78#530. 1998.
"Extra-cranial Stereotactic Radioablation." American Academy of Medical Dosimetrists Regional Meeting. Myrtle Beach, SC. April 7, 2006.
"Encouraging Early Results Using the GliaSite Brachytherapy Device as a Portion of Initial Therapy for Malignant Gliomas." 2004 GliaSite Physician Conference. Chicago, Illinois. August 7, 2004.
"Clinical Trial Development and Participation." Society of Radiation Oncology Administrators: Southeast Regional Meeting. Charlotte, NC. June 26, 2004.
"Intensity Modulated Radiation Therapy: The Future of Radiation Therapy." Grand Rounds at Gaston Memorial Hospital. Gastonia, North Carolina. November 26, 2002.
"Prostate Cancer and Intensity Modulated Radiation Therapy (IMRT)" Varian Sponsored IMRT Symposium. Charlotte, North Carolina. May 21, 2001.
"New Techniques in Radiation Therapy: Stereotactic Radiosurgery, Stereotactic Radiotherapy, and IMRT" William R. Pitts Neuroscience Symposium. Charlotte, North Carolina. May 1, 2001.
"IMRT and Prostate Cancer" South Carolina Oncology Associates Annual Meeting. Columbia, South Carolina. April 21, 2001.
Co-Principal Investigator: "A Prospective Analysis of Neoadjuvant Radiosurgery and Surgical Resection for the Treatment of 1-3 Cerebral Metastases" Carolinas Medical Center
National Radiation Oncology Study Chair. American College of Surgeons Oncology Group#Z0300: A Phase III Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to Radiosurgery in the Management of Patients with One to Three Cerebral Metastases.
Radiation Oncology Study Chair for multi-institutional study. Temozolomide as Neoadjuvant and Chemo-radiotherapy Following Resection and GLIADEL® Wafer Placement in Patients With Newly Diagnosed High-grade Glioma.
AMA, ASTRO, SNO, ACR
Editorial review board for the International Journal of Radiation Oncology Biology Physics. 2007-present.
ACR and ASTRO joint committee to develop the "ACR Practice Guideline for the performance of stereotactic radiosurgery." 2005
ASTRO Central Nervous System abstract review committee. 2004.
American College of Surgeons Oncology Group Central Nervous System Committee. 2000-present.
Committee on Graduate Medical Education: July 1997-June 1998
